- Home
- HG vs CNTA Comparison
HG vs CNTA Comparison
Compare HG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HG | CNTA |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | Bermuda | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HG | CNTA |
|---|---|---|
| Price | $26.40 | $29.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $29.00 | ★ $35.00 |
| AVG Volume (30 Days) | 486.4K | ★ 2.1M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.19 | N/A |
| Revenue | ★ $2,745,461,000.00 | $15,000,000.00 |
| Revenue This Year | $25.41 | N/A |
| Revenue Next Year | $0.82 | N/A |
| P/E Ratio | $6.31 | ★ N/A |
| Revenue Growth | 21.12 | ★ 118.88 |
| 52 Week Low | $16.80 | $9.60 |
| 52 Week High | $27.88 | $30.00 |
Technical Indicators
Market Signals| Indicator | HG | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 53.45 | 68.32 |
| Support Level | $25.93 | $28.19 |
| Resistance Level | $27.88 | $29.77 |
| Average True Range (ATR) | 0.67 | 1.35 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 37.55 | 91.58 |
Price Performance
Historical ComparisonAbout HG Hamilton Insurance Group Ltd. Class B
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.